BPI
ABVX icon

BFC Planning, Inc.’s Abivax ABVX Stock Holding History

BFC Planning, Inc.’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$192K Sell
1,439
-47
-3% -$5.32K 0.01% 948
2026
Q1 		$165K Buy
1,486
+11
+0.7% +$1.3K 0.01% 937
2025
Q4 		$199K Buy
+1,475
New +$161K 0.01% 869

Other funds holding ABVX

TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Helikon Investments
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Vestal Point Capital
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
ADAR1 Capital Management
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Caligan Partners
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BFC Planning, Inc.'s ABVX Position: Q2 2026 in Review

BFC Planning, Inc. reduced its Abivax (ABVX) stake by 3.2% in Q2 2026, selling an estimated $5.32K and leaving 1,439 shares worth $192K. The position accounts for 0.01% of the portfolio, ranked #948.

BFC Planning, Inc. first reported a position in ABVX in Q4 2025 and has held it in 3 quarters since. The position peaked at $199K in Q4 2025. 307 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • BFC Planning, Inc. held 1,439 shares of Abivax worth $192K as of Q2 2026.
  • BFC Planning, Inc. sold 47 Abivax shares in Q2 2026, an estimated $5.32K.
  • Abivax made up 0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #948 holding.
  • BFC Planning, Inc. first reported a position in Abivax in Q4 2025 and has held it in 3 quarters since.
  • BFC Planning, Inc.'s Abivax position peaked at $199K in Q4 2025.
  • 307 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.